Details for New Drug Application (NDA): 050729
✉ Email this page to a colleague
The generic ingredient in AMPHOTEC is amphotericin b. There are fifteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the amphotericin b profile page.
Summary for 050729
Tradename: | AMPHOTEC |
Applicant: | Alkopharma Usa |
Ingredient: | amphotericin b |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 050729
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE, LIPID COMPLEX;INJECTION | Strength | 50MG/VIAL | ||||
Approval Date: | Nov 22, 1996 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE, LIPID COMPLEX;INJECTION | Strength | 100MG/VIAL | ||||
Approval Date: | Nov 22, 1996 | TE: | RLD: | No |
Complete Access Available with Subscription